KU 55933
Tocris Bioscience, part of Bio-Techne | Catalog # 3544
Potent and selective ATM kinase inhibitor
Key Product Details
Description
Potent and selective ATM kinase inhibitor
Product Description
KU 55933 is a potent, selective and competitive ATM kinase inhibitor (Ki = 2.2 nM, IC50 values are 13, 2500, 9300, 16600, > 100000 and > 100000 nM at ATM, DNA-PK, mTOR, PI 3-kinase, PI 4-K and ATR respectively). Decreases viability of MCF-7, A549 and HCT116 cells and decreases p21CIP1 levels in vitro. Acts as a radio- and chemosensitizer for the treatment of cancer.Product Specifications
Molecular Weight
395.49
Formula
C21H17NO3S2
Storage
Desiccate at -20°C
Purity
≥98% (HPLC)
Chemical Name
2-(4-Morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one
CAS Number
587871-26-9
PubChem ID
5278396
InChI Key
XRKYMMUGXMWDAO-UHFFFAOYSA-N
SMILES
O=C1C=C(C3=CC=CC4=C3SC5=C(C=CC=C5)S4)OC(N2CCOCC2)=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 39.55 | 100 | |
| Ethanol | 19.77 | 50 |
Preparing Stock Solutions
for KU 55933
The following data is based on the product molecular weight 395.49
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.53 mL | 12.64 mL | 25.29 mL |
| 5 mM | 0.51 mL | 2.53 mL | 5.06 mL |
| 10 mM | 0.25 mL | 1.26 mL | 2.53 mL |
| 50 mM | 0.05 mL | 0.25 mL | 0.51 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Eaton Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis. J.Clin.Invest. 2007 PMID: 17786248
- Crescenzi Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy. Clin.Cancer Res. 2008 PMID: 18347191
- Hickson Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004 PMID: 15604286
Product Specific Notices for KU 55933
For research use only
Loading...
Loading...
Loading...